Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 2/20 | 0.87 |
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.87 |
| ▸ | EP300 | Q09472 | 4/20 | 0.86 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.86 |
| ▸ | AURKA | O14965 | 2/20 | 0.86 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.86 |
| ▸ | NAA40 | Q86UY6 | 1/20 | 0.79 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19211093 | 1.00 | CHAT (0.87) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL29423878 | 0.95 | CHAT (0.87) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL18608119 | 0.95 | CHAT (0.87) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL29613056 | 0.95 | CHAT (0.84) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL22125027 | 0.95 | CHAT (0.84) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL13735029 | 0.95 | CHAT (0.84) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL18250353 | 0.95 | CHAT (0.86) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL16154933 | 0.95 | CHAT (0.86) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL22810879 | 0.95 | CHAT (0.86) | CHATNAA50EP300KAT5AURKA | |
| SCHEMBL16856326 | 0.95 | CHAT (0.86) | CHATNAA50EP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120738232-A | Bacterial strain fermentation method for synthesizing sclareol | 武穴格莱默生物科技有限公司 | 2025-10-03 | — | — | CN | disclosed |
| CN-117778218-A | Recombinant yarrowia lipolytica capable of producing abscisic acid in high yield as well as construction method and application thereof | 南京工业大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-116656512-A | Sclareum endophytic fungus and screening separation and application thereof | 广西科学院 | 2023-08-29 | — | — | CN | disclosed |
| CN-115916994-A | Detection of methylcytosine and its derivatives using S-adenosyl-L-methionine analogue (xSAM) | 伊鲁米那股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| US-20220290234-A1 | DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) | ILLUMINA, INC. (US) | 2022-09-15 | — | — | US | disclosed |
| US-20220023274-A1 | USE OF A BERBERIS AND RESVERATROL MIXTURE TO CONTROL DYSLIPIDEMIA | S&R FARMACEUTICI S.P.A. (IT) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220290234-A1 | DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) | MTAP, RNMT, RNGTT | CHAT 935/4885NAA50 844/4885EP300 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.